Show simple item record

dc.contributor.authorFang, Margaret C.
dc.contributor.authorCoca Perraillon, Marcelo
dc.contributor.authorGhosh, Kaushik
dc.contributor.authorCutler, David M.
dc.contributor.authorRosen, Allison B.
dc.date.accessioned2017-07-20T21:03:38Z
dc.date.issued2014
dc.identifier.citationFang, Margaret C., Marcelo Coca Perraillon, Kaushik Ghosh, David M. Cutler, and Allison B. Rosen. 2014. “Trends in Stroke Rates, Risk, and Outcomes in the United States, 1988 to 2008.” The American Journal of Medicine 127 (7) (July): 608–615. doi:10.1016/j.amjmed.2014.03.017.en_US
dc.identifier.issn0002-9343en_US
dc.identifier.urihttp://nrs.harvard.edu/urn-3:HUL.InstRepos:33471116
dc.description.abstractBackground Stroke is a major cause of morbidity and mortality. We describe trends in the incidence, outcomes, and risk factors for stroke in the US Medicare population from 1988 to 2008. Methods We analyzed data from a 20% sample of hospitalized Medicare beneficiaries with a principal discharge diagnosis of ischemic (n = 918,124) or hemorrhagic stroke (n = 133,218). Stroke risk factors were determined from the National Health and Nutrition Examination Survey (years 1988-1994, 2001-2008) and medication uptake from the Medicare Current Beneficiary Survey (years 1992-2008). Primary outcomes were stroke incidence and 30-day mortality after stroke hospitalization. Results Ischemic stroke incidence decreased from 927 per 100,000 in 1988 to 545 per 100,000 in 2008, and hemorrhagic stroke decreased from 112 per 100,000 to 94 per 100,000. Risk-adjusted 30-day mortality decreased from 15.9% in 1988 to 12.7% in 2008 for ischemic stroke and from 44.7% to 39.3% for hemorrhagic stroke. Although observed stroke rates decreased, the Framingham stroke model actually predicted increased stroke risk (mean stroke score 8.3% in 1988-1994, 8.8% in 2005-2008). Statin use in the general population increased (4.0% in 1992, 41.4% in 2008), as did antihypertensive use (53.0% in 1992, 73.5% in 2008). Conclusions Incident strokes in the Medicare population aged ≥65 years decreased by approximately 40% over the last 2 decades, a decline greater than expected on the basis of the population's stroke risk factors. Case fatality from stroke also declined. Although causality cannot be proven, declining stroke rates paralleled increased use of statins and antihypertensive medications.en_US
dc.description.sponsorshipEconomicsen_US
dc.language.isoen_USen_US
dc.publisherElsevier BVen_US
dc.relation.isversionofdoi:10.1016/j.amjmed.2014.03.017en_US
dash.licenseMETA_ONLY
dc.subjectAntihypertensive medicationsen_US
dc.subjectHemorrhagic strokeen_US
dc.subjectIschemic strokeen_US
dc.subjectMortalityen_US
dc.subjectOutcomesen_US
dc.subjectRisken_US
dc.subjectStatinsen_US
dc.subjectStrokeen_US
dc.subjectTrendsen_US
dc.titleTrends in Stroke Rates, Risk, and Outcomes in the United States, 1988 to 2008en_US
dc.typeJournal Articleen_US
dc.date.updated2014-07-24T18:46:36Z
dc.description.versionVersion of Recorden_US
dc.relation.journalThe American Journal of Medicineen_US
dash.depositing.authorCutler, David M.
dash.embargo.until10000-01-01
dc.identifier.doi10.1016/j.amjmed.2014.03.017*
dash.contributor.affiliatedCutler, David


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record